Wellington Management Company

Portfolio Companies 2026 for Wellington Management Company: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Wellington Management Company accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $5.6B. The median disclosed raise is $181M, and the largest is Kymera Therapeutics at $3B, ahead of Gracell Biotechnologies ($520M) and Porch Group ($322M).

The names that recur most often on these portfolio cap tables are Wellington Management Company (14 companies), Janus Henderson Investors (4 companies), Logos Capital (4 companies), Redmile Group (3 companies), BlackRock (3 companies), Vivo Capital (3 companies). By latest disclosed round, the market skews Series C (4), Series B (4), IPO (3).

Best funded Wellington Management Company companies

  1. Kymera Therapeutics — $3B (latest: Series C)
  2. Gracell Biotechnologies — $520M (latest: IPO)
  3. Porch Group — $322M (latest: IPO)
  4. Spur Therapeutics — $274M
  5. Aligos Therapeutics — $225M (latest: Series B)
  6. Black Diamond Therapeutics — $194M (latest: Series C)
  7. UNUM Therapeutics — $181M (latest: Series B)
  8. Goldfinch Biopharma — $160M (latest: Series B)
  9. ZipRecruiter — $156M
  10. Nurix — $120M
  11. Porch — $119M (latest: IPO)
  12. Jounce Therapeutics — $103M (latest: Series B)
  13. Allena Pharmaceuticals — $96M (latest: Series C)
  14. Olema Oncology — $85M (latest: Series C)

Wellington Management Company LLP — related firms and companies (45)

Wellington Management Company LLP profile · All research reports